@article{9ab4b3337c364560b2fc2843231413bf,
title = "Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection",
author = "Paolo Strati and Nastoupil, {Loretta J.} and Fayad, {Luis E.} and Felipe Samaniego and Sherry Adkins and Neelapu, {Sattva S.}",
note = "Funding Information: Conflict-of-interest disclosure: S.S.N. reports honoraria and research support from Kite, a Gilead Company, Merck, and Celgene; research support from Bristol-Myers Squibb, Poseida, Cellectis, Karus, and Acerta Pharma; and honoraria from Novartis, Pfizer, and Unum Therapeutics. F.S. reports honoraria from Celgene. L.J.N. reports honoraria from Celgene, Genentech, Gilead, Janssen, Juno, Novartis, and Spectrum and research support from Celgene, Genentech, Janssen, and Merck. The remaining authors declare no competing financial interests.",
year = "2019",
month = jun,
day = "27",
doi = "10.1182/blood.2019000888",
language = "English (US)",
volume = "133",
pages = "2800--2802",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "26",
}